Velorum Therapeutics is a biotechnology startup dedicated to developing breakthrough medicines by researching the biological properties of heme. The company operates in the healthcare and therapeutics sectors, focusing on drug discovery to address complex medical conditions.
Velorum Therapeutics was founded by the Velorum Therapeutics Team. This group leads the company's efforts in San Francisco, CA, focusing on full-time research and development within the biotech industry.
Velorum Therapeutics utilizes its research into heme biology to innovate within the field of oncology. By unlocking specific biological mechanisms, the company aims to discover and develop new therapeutic treatments for cancer patients.
Velorum Therapeutics is headquartered in San Francisco, CA. The company maintains a remote-friendly work policy for its full-time team members while remaining active in the California biotech hub.
Velorum Therapeutics addresses the need for novel medical treatments by focusing on the untapped potential of heme biology. This specialized approach to drug discovery allows them to create medicines for various therapeutic areas, including oncology and general healthcare.
Yes, Velorum Therapeutics is currently in the launched stage of its operations. It is a full-time venture that has established its presence in the biotech industry as part of the Y Combinator ecosystem.